SUZANNE M FORTUNA
Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner CLEVELAND, OH NPI 1679669592
Browse related groups: Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner OH ABBVIE INC. All categories
General Payments — all program years on this page
$6,739.82
- Category: General Payments
- Program years: PY2021–2024
- Record count: 67
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $2,823.39 across 29 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $2,823.39 | 29 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $927.98 | 10 |
| Phathom Pharmaceuticals, Inc. | $375.00 | 3 |
| Inspire Medical Systems, Inc. | $168.72 | 2 |
| JAZZ PHARMACEUTICALS INC. | $130.84 | 1 |
| E.R. Squibb & Sons, L.L.C. | $126.24 | 1 |
| Alexion Pharmaceuticals, Inc. | $124.99 | 1 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $119.84 | 1 |
| Lucid Diagnostics Inc. | $117.18 | 1 |
| Kiniksa Pharmaceuticals International, plc | $109.72 | 1 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | $96.97 | 1 |
| Gilead Sciences, Inc. | $92.99 | 1 |
| COLOPLAST CORP | $80.31 | 1 |
| Aurinia Pharma U.S., Inc. | $78.24 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $77.65 | 1 |
| UCB, Inc. | $72.80 | 1 |
| Neurelis, Inc. | $64.44 | 1 |
| GENZYME CORPORATION | $59.48 | 1 |
By program year
Records — PY2024 (29)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.